Neoplasms and pathology of sexual developmental disorders (intersex)

Pathology

Volumn 39, Issue 1, 2007, Pages 147-163

  Robboy, Stanley J ^a   Jaubert, Francis ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Necker Enfants Malades ^*  (France)

Author keywords

Adrenogenital syndrome; Leydig cell deficiency; Male pseudohermaphroditism; Maternal ingestion of progestins or androgens; Maternal virilising lesions; Placental aromatase defect; Smith Lemli Opitz syndrome; Testicular regression syndrome

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CHORIONIC GONADOTROPIN; CORTICOTROPIN; DIETHYLSTILBESTROL; ETHISTERONE; FOLLITROPIN; GESTAGEN; ISOENZYME; LUTEINIZING HORMONE; MESTRANOL PLUS NORETYNODREL; MITOTANE; NORETHISTERONE; PROGESTERONE; TESTOSTERONE;

17 HYDROXYSTEROID DEHYDROGENASE DEFICIENCY; 17,20 DESMOLASE DEFICIENCY; 20,22 DESMOLASE DEFICIENCY; 3 BETA HYDROXYLASE DEHYDROGENASE DEFICIENCY; ANDROGEN DEFICIENCY; ARTICLE; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; CRYPTORCHISM; DENYS DRASH SYNDROME; DEVELOPMENTAL DISORDER; ENZYME DEFICIENCY; FEMALE PSEUDOHERMAPHRODITISM; FETUS DEVELOPMENT; FRASIER SYNDROME; GENE DELETION; GENE MUTATION; GONAD TUMOR; GONADAL DISEASE; GONADAL DYSGENESIS; GONADOBLASTOMA; HERNIORRHAPHY; HORMONE BLOOD LEVEL; HORMONE METABOLISM; HUMAN; HYPOSPADIAS; HYSTERECTOMY; KARYOTYPE; KLINEFELTER SYNDROME; LEYDIG CELL; LEYDIG CELL DEFICIENCY; MALE PSEUDOHERMAPHRODITISM; MICROPENIS; MOSAICISM; MUTATIONAL ANALYSIS; NEPHROBLASTOMA; ORCHIDOPEXY; PERSISTENT MULLERIAN DUCT SYNDROME; PLACENTA AROMATASE DEFICIENCY; SALPINGECTOMY; SEXUAL DEVELOPMENT; SMITH LEMLI OPITZ SYNDROME; TESTIS REGRESSION SYDROME; TRUE HERMAPHRODITISM; TURNER SYNDROME; VIRILIZATION; XX MALE SYNDROME; Y CHROMOSOME;

FEMALE; HERMAPHRODITISM; HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; SEX DIFFERENTIATION DISORDERS;

EID: 33847179846     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020601137359     Document Type: Article

References (118)

1. Morel Y, Rey R, Teinturier C, et al. Aetiological diagnosis of male sex ambiguity: a collaborative study. Eur J Pediatr 2002; 161: 49-59.
2. Jaubert F, Nihoul-Fekete C, Lortat-Jacob S, et al. Hermaphroditism pathology. (French.) Ann Pathol 2004; 24: 499-509.
3. Dreger AD, Chase C, Sousa A, et al. Changing the nomenclature/taxonomy for intersex: A scientific and clinical rationale. J Pediatr Endocrinol Metab 2005; 18: 729.
4. Carlson AD, Obeid JS, Kanellopoulou N, et al. Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment. J Steroid Biochem Mol Biol 1999; 69: 19-29.
5. New MI. Diagnosis and management of congenital adrenal hyperplasia. Ann Review Med 1998; 49: 311-28.
6. Newfield RS, New MI. 21-hydroxylase deficiency. Ann NY Acad Sci 1997; 816: 219-29.
7. Cerame BI, Newfield RS, Pascoe L, et al. Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia. J Clin Endocrinol Metab 1999; 84: 3129-34.
8. Ferrari P, Obeyesekere VR, Li K, et al. Point mutations abolish 11 beta-hydroxysteroid dehydrogenase type II activity in three families with the congenital syndrome of apparent mineralocorticoid excess. Mol Cell Endocrinol 1996; 119: 21-4.
9. Rich MA, Keating MA, Levin HS, et al. Tumors of the adrenogenital syndrome: An aggressive conservative approach. J Urol 1998; 160: 1838-41.
10. Rutgers JL, Young RH, Scully RE. The testicular 'tumor' of the adrenogenital syndrome. A report of six cases and review of the literature on testicular masses in patients with adrenocortical disorders. Am J Surg Pathol 1988; 12: 503-13.
11. Avila NA, Premkumar A, Merke DP. Testicular adrenal rest tissue in congenital adrenal hyperplasia: Comparison of MR imaging and sonographic findings. Am J Roentgenol 1999; 172: 1003-6.
12. Al-Ahmadie HA, Stanek J, Liu J, et al. Ovarian 'tumor' of the adrenogenital syndrome - the first reported case. Am J Surg Pathol 2001; 25: 1443-50.
13. Bas F, Saka N, Darendeliler F, et al. Bilateral ovarian steroid cell tumor in congenital adrenal hyperplasia due to classic 11beta-hydroxylase deficiency. J Pediatr Endocrinol Metab 2000; 13: 663-7.
14. MacGillivray MH, Morishima A, Conte F, et al. Pediatric endocrinology update: an overview. The essential roles of estrogens in pubertal growth, epiphyseal fusion and bone turnover: lessons from mutations in the genes for aromatase and the estrogen receptor. Hormone Res 1998; 49: 2-8.
15. Shozu M, Akasofu K, Harada T, et al. A new cause of female pseudohermaphroditism: placental aromatase deficiency. J Clin Endocrinol Metab 1991; 72: 560-6.
16. Vauthier-Brouzes D, Vanna Lim-You K, Sebagh E, et al. Krukenberg tumor during pregnancy with maternal and fetal virilization: a difficult diagnosis. A case report. J Gynecol Obstet Biol Reprod (Paris) 1997; 26: 831-3.
17. Mazza V, Di Monte I, Ceccarelli PL, et al. Prenatal diagnosis of female pseudohermaphroditism associated with bilateral luteoma of pregnancy. Hum Reprod 2002; 17: 821-4.
18. Cendron M, Schned AR, Ellsworth PI. Histological evaluation of the testicular nubbin in the vanishing testis syndrome. J Urol 1998; 160 (3 Pt 2): 1161-3.
19. Merry C, Sweeney B, Puri P. The vanishing testis: Anatomical and histological findings. Eur Urol 1997; 31: 65-6.
20. Spires SE, Woolums CS, Pulito AR, et al. Testicular regression syndrome - A clinical and pathologic study of 11 cases. Arch Pathol Lab Med 2000; 124: 694-8.
21. Arnhold IJ, Latronico AC, Batista MC, et al. Menstrual disorders and infertility caused by inactivating mutations of the luteinizing hormone receptor gene. Fertil Steril 1999; 71: 597-601.
22. Fitzky BU, Glossmann H, Utermann G, et al. Molecular genetics of the Smith-Lemli-Opitz syndrome and postsqualene sterol metabolism. Curr Opin Lipidol 1999; 10: 123-31.
23. Nowaczyk MJ, Whelan DT, Heshka TW, et al. Smith-Lemli-Opitz syndrome: a treatable inherited error of metabolism causing mental retardation. Can Med Assoc J 1999; 161: 165-70.
24. Opitz JM. RSH (so-called Smith-Lemli-Opitz) syndrome. Current Opin Pediatr 1999; 11: 353-62.
25. Porter FD. Human malformation syndromes due to inborn errors of cholesterol synthesis. Curr Opin Pediatr 2003; 15: 607-13.
26. Fukazawa R, Nakahori Y, Kogo T, et al. Normal Y sequences in Smith-Lemli-Opitz syndrome with total failure of masculinization. Acta Paediatr 1992; 81: 570-2.
27. Berensztein E, Torrado M, Belgorosky A, et al. Smith-Lemli-Opitz syndrome: in vivo and in vitro study of testicular function in a prepubertal patient with ambiguous genitalia. Acta Paediatr 1999; 88: 1229-32.
28. Korsch E, Peter M, Hiort O, et al. Gonadal histology with testicular carcinoma in situ in a 15-year-old 46,XY female patient with a premature termination is the steroidogenic acute regulatory protein causing congenital lipoid adrenal hyperplasia. J Clin Endocrinol Metabol 1999; 84: 1628-32.
29. Mendonca BB, Inacio M, Arnhold IJP, et al. Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase 3 deficiency - Diagnosis, psychological evaluation, and management. Medicine (Baltimore) 2000; 79: 299-309.
30. Zhu YS, Katz MD, Imperato-McGinley J. Natural potent androgens: lessons from human genetic models. Baillieres Clin Endocrinol Metab 1998; 12: 83-113.
31. Andersson S, Moghrabi N. Physiology and molecular genetics of 17 beta-hydroxysteroid dehydrogenases. Steroids 1997; 62: 143-7.
32. Buchholz NP, Biyabani R, Herzig MJU, et al. Persistent mullerian duct syndrome. Eur Urol 1998; 34: 230-2.
33. Lima M, Domini M, Libri M. Persistent mullerian duct syndrome associated with transverse testicular ectopia: A case report. Eur J Pediatr Surg 1997; 7: 60-2.
34. Rizk DEE, Ezimokhai M, Hussein AS, et al. Persistent Mullerian duct syndrome. Arch Gynecol Obstet 1998; 261: 105-7.
35. Belville C, Josso N, Picard JY. Persistence of Mullerian derivatives in males. Am J Med Genet 1999; 89: 218-23.
36. Josso N, Belville C, di Clemente N, et al. AMH and AMH receptor defects in persistent Mullerian duct syndrome. Hum Reprod Update 2005; 11: 351-6.
37. Shinmura Y, Yokoi T, Tsutsui Y. A case of clear cell adenocarcinoma of the mullerian duct in persistent mullerian duct syndrome: the first reported case. Am J Surg Pathol 2002; 26: 1231-4.
38. Alvarez-Nava F, Gonzalez S, Soto M, et al. Complete androgen insensitivity syndrome: clinical and anatomopathological findings in 23 patients. Genetic Counsel 1997; 8: 7-12.
39. Viner RM, Teoh Y, Williams DM, Patterson MN, et al. Androgen insensitivity syndrome: a survey of diagnostic procedures and management in the UK. Arch Dis Child 1997; 77: 305-9.
40. Rutgers JL, Scully RE. The androgen insensitivity syndrome (testicular feminization): a clinicopathologic study of 43 cases. Int J Gynecol Pathol 1991; 10: 126-44.
41. Velidedeoglu HV, Coskunfirat OK, Bozdogan MN, et al. The surgical management of incomplete testicular feminization syndrome in three sisters. Br J Plastic Surg 1997; 50: 212-6.
42. Regadera J, Martinez Garcia F, Paniagua R, et al. Androgen insensitivity syndrome - An immunohistochemical, ultrastructural, and morphometric study. Arch Pathol Lab Med 1999; 123: 225-34.
43. Hawkyard S, Poon P, Morgan DR. Sertoli tumour presenting with stress incontinence in a patient with testicular feminization. Br J Urol Int 1999; 84: 382-3.
44. Iwamoto I, Yanazume S, Fujino T, et al. Leydig cell tumor in an elderly patient with complete androgen insensitivity syndrome. Gynecol Oncol 2005; 96: 870-2.
45. McNeill SA, O'Donnell M, Donat R, et al. Estrogen secretion from a malignant sex cord stromal tumor in a patient with complete androgen insensitivity. Am J Obstet Gynecol 1997; 177: 1541-2.
46. Manuel M, Katayama PK, Jones HW Jr. The age of occurrence of gonadal tumors in intersex patients with a Y chromosome. Am J Obstet Gynecol 1976; 124: 293-300.
47. Imperato-McGinley J. 5 alpha-reductase-2 deficiency. Curr Ther Endocrinol Metab 1997; 6: 384-7.
48. Sinnecker GH, Hiort O, Dibbelt L, et al. Phenotypic classification of male pseudohermaphroditism due to steroid 5 alpha-reductase 2 deficiency. Am J Med Genet 1996; 63: 223-30.
49. Aartsen EJ, Snethlage RAI, Vangeel AN, et al. Squamous cell carcinoma of the vagina in a male pseudohermaphrodite with 5 alpha-Reductase deficiency. Int J Gynecol Cancer 1994; 4: 283-7.
50. Lanfranco F, Kamischke A, Zitzmann M, et al. Klinefelter's syndrome. Lancet 2004; 364: 273-83.
51. Aksglaede L, Wikstrom AM, Rajpert-De Meyts E, et al. Natural history of seminiferous tubule degeneration in Klinefelter syndrome. Hum Reprod Update 2006; 12: 39-48.
52. Hunter RHF. Abnormal sexual development in man. In: Hunter RH.F, editor. Sex Determination, Differentiation and Intersexuality in Placental Mammals. Cambridge: Cambridge University Press, 1995; 204-38.
53. Matsuki S, Sasagawa I, Kakizaki H, et al. Testicular teratoma in a man with XX/XXY mosaic Klinefelter's syndrome. J Urol 1999; 161: 1573-4.
54. Okada H, Gotoh A, Takechi Y, Kamidono S. Leydig cell tumour of the testis associated with Klinefelter's syndrome and Osgood-Schlatter disease. Br J Urol 1994; 73: 457.
55. Jacobs P, Dalton P, James R, et al. Turner syndrome: a cytogenetic and molecular study. Ann Hum Genet 1997; 61 (Pt 6): 471-83.
56. Martinez-Pasarell O, Nogues C, Bosch M, et al. Analysis of sex chromosome aneuploidy in sperm from fathers of Turner syndrome patients. Hum Genet 1999; 104: 345-9.
57. Gravholt CH, Fedder J, Naeraa RW, et al. Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material: a population study. J Clin Endocrinol Metab 2000; 85: 3199-202.
58. Brant WO, Rajimwale A, Lovell MA, et al. Gonadoblastoma and Turner syndrome. J Urol 2006; 175: 1858-60.
59. Canto P, Kofman-Alfaro S, Jimenez AL, et al. Gonadoblastoma in Turner syndrome patients with nonmosaic 45,X karyotype and Y chromosome sequences. Cancer Genet Cytogenet 2004; 150: 70-2.
60. Lvarez-Nava AF, Soto M, Sanchez MA, et al. Molecular analysis in Turner syndrome. J Pediatr 2003; 142: 336-40.
61. Mazzanti L, Cicognani A, Baldazzi L, et al. Gonadoblastoma in Turner syndrome and Y-chromosome-derived material. Am J Med Genet A 2005; 135: 150.
62. Mendes JRT, Strufaldi MWL, Delcelo R, et al. Y-chromosome identification by PCR and gonadal histopathology in Turner's syndrome without overt Y-mosaicism. Clin Endocrinol 1999; 50: 19-26.
63. Nazarenko SA, Timoshevsky VA, Sukhanova NN. High frequency of tissue-specific mosaicism in Turner syndrome patients. Clin Genet 1999; 56: 59-65.
64. Patsalis PC, Sismani C, Hadjimarcou MI, et al. Detection and incidence of cryptic Y chromosome sequences in Turner syndrome patients. Clin Genet 1998; 53: 249-57.
65. Park JP, Brothman AR, Butler MG, et al. Extensive analysis of mosaicism in a case of Turner syndrome: the experience of 287 cytogenetic laboratories. College of American Pathologists/American College of Medical Genetics Cytogenetics Resource Committee. Arch Pathol Lab Med 1999; 123: 381-5.
66. Chu C. Y-chromosome mosaicism in girls with Turner's syndrome. Clin Endocrinol 1999; 50: 17-8.
67. Watanabe M, Zinn AR, Page DC, et al. Functional equivalence of human X- and Y-encoded isoforms of ribosomal protein S4 consistent with a role in Turner syndrome. Nat Genet 1993; 4: 268-71.
68. Gicquel C, Gaston V, Cabrol S. Assessment of Turner's syndrome by molecular analysis of the X chromosome in growth-retarded girls. J Clin Endocrinol Metab 1998; 83: 1472-6.
69. Hovatta O. Pregnancies in women with Turner's syndrome. Ann Med 1999; 31: 106-10.
70. Magee AC, Nevin NC, Armstrong MJ, et al. Ullrich-Turner syndrome: seven pregnancies in an apparent 45,X woman. Am J Med Genet 1998; 75: 1-3.
71. Foudila T, Soderstrom-Anttila V, Hovatta O. Turner's syndrome and pregnancies after oocyte donation. Hum Reprod 1999; 14: 532-5.
72. Reynaud K, Cortvrindt R, Verlinde F, et al. Number of ovarian follicles in human fetuses with the 45,X karyotype. Fertil Steril 2004; 81: 1112-9.
73. Pierga JY, Giacchetti S, Vilain E, et al. Dysgerminoma in a pure 45,X turner syndrome: report of a case and review of the literature. Gynecol Oncol 1994; 55: 459-64.
74. Ito K, Kawamata Y, Osada H, Ijichi M, et al. Pure yolk sac tumor of the ovary with mosaic 45X/46X+mar Turner's syndrome with a Y-chromosomal fragment. Arch Gynecol Obstet 1998; 262: 87-90.
75. Vanderbijl AE, Fleuren GJ, Kenter GG, et al. Unique combination of an ovarian gonadoblastoma, dysgerminoma, and mucinous cystadenoma in a patient with turners syndrome - a cytogenetic and molecular analysis. Int J Gynecol Pathol 1994; 13: 267-72.
76. Kocova M, Basheska N, Papazovska A, et al. Girls with Turner's syndrome with spontaneous menarche have an increased risk of endometrial carcinoma: a case report and review from the literature. Gynecol Oncol 2005; 96: 840.
77. Tateno T, Sasagawa I, Ashida J, et al. Deletion of Y chromosome involving the DAZ (deleted in azoospermia) gene in XX males. Arch Androl 1999; 42: 179-83.
78. Ginsberg NA, Cadkin A, Strom C, et al. Prenatal diagnosis of 46,XX male fetuses. Am J Obstet Gynecol 1999; 180: 1006-7.
79. Lam SK, Yu MY, To KF, Chan MKM, et al. Ovarian epithelial tumour in gonadal dysgenesis a case report and literature review. Aust NZ J Obstet Gynaecol 1996; 36: 106-9.
80. Morimura Y, Nishiyama H, Yanagida K, et al. Dysgerminoma with syncytiotrophoblastic giant cells arising from 46,xx pure gonadal dysgenesis. Obstet Gynecol 1998; 92 (Suppl): 654-6.
81. Uehara S, Funato T, Yaegashi N, et al. SRY mutation and tumor formation on the gonads of XY pure gonadal dysgenesis patients. Cancer Genet Cytogenet 1999; 113: 78-84.
82. Radakovic B, Jukic S, Bukovic D, et al. Morphology of gonads in pure XY gonadal dysgenesis. Coll Antropol 1999; 23: 203-11.
83. Barbosa AS, Hadjiathanasiou CG, Theodoridis C, et al. The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor. Hum Mutat 1999; 13: 146-53.
84. Jaubert F, Vasiliu V, Patey-Mariaud de Serre N, et al. Gonad development in Drash and Frasier syndromes depends on WT1 mutations. Arkh Patol 2003; 65: 40-4.
85. Auber F, Lortat-Jacob S, Sarnacki S, et al. Surgical management and genotype/phenotype correlations in WT1 gene-related diseases (Drash, Frasier syndromes). J Pediatr Surg 2003; 38: 124-9.
86. Saxena AK, van Tuil C, Schultze-Everding A. Frasier syndrome in a pre-menarchal girl: laparoscopic resection of gonadoblastoma. Eur J Pediatr 2006; 165: 917-9.
87. Wang NJ, Song HR, Schanen NC, et al. Frasier syndrome comes full circle: genetic studies performed in an original patient. J Pediatr 2005; 146: 843-4.
88. Bonte A, Schroder W, Denamur E, et al. Absent pubertal development in a child with chronic renal failure: the case of Frasier syndrome. Nephrol Dial Transplant 2000; 15: 1688-90.
89. Perez de Nanclares G, Castano L, Bilbao JR, et al. Molecular analysis of Frasier syndrome: mutation in the WT1 gene in a girl with gonadal dysgenesis and nephronophthisis. J Pediatr Endocrinol Metab 2002; 15: 1047-50.
90. Niaudet P, Gubler MC. WT1 and glomerular diseases. Pediatr Nephrol 2006; 21: 1653-60.
91. Alvarez-Nava F, Gonzalez S, Soto M, et al. Mixed gonadal dysgenesis: A syndrome of broad clinical cytogenetic and histopathologic spectrum. Genet Couns 1999; 10: 233-43.
92. Reiner WG. Assignment of sex in neonates with ambiguous genitalia. Curr Opin Pediatr 1999; 11: 363-5.
93. Alvarez-Nava F, Martinez MC, Gonzalez S, et al. FISH and PCR analysis of the presence of Y-chromosome sequences in a patient with Xq-isochromosome and testicular tissue. Clin Genet 1999; 55: 356-61.
94. Telvi L, Lebbar A, Del Pino O, et al. 45,X/46,XY mosaicism: report of 27 cases. Pediatrics 1999; 104: 304-8.
95. Gibbons B, Tan SY, Yu CC, et al. Risk of gonadoblastoma in female patients with Y chromosome abnormalities and dysgenetic gonads. J Paediatr Child Health 1999; 35: 210-3.
96. Mendez JP, Ulloa-Aguirre A, Kofman-Alfaro S, et al. Mixed gonadal dysgenesis: clinical, cytogenetic, endocrinological, and histopathological findings in 16 patients. Am J Med Genet 1993; 46: 263-7.
97. Robboy SJ, Miller T, Donahoe PK, et al. Dysgenesis of testicular and streak gonads in the syndrome of mixed gonadal dysgenesis: perspective derived from a clinicopathologic analysis of twenty-one cases. Hum Pathol 1982; 13: 700-16.
98. Nomura K, Matsui T, Aizawa S. Gonadoblastoma with proliferation resembling Sertoli cell tumor. Int J Gynecol Pathol 1999; 18: 91-3.
99. Pena-Alonso R, Nieto K, Alvarez R, et al. Distribution of Y-chromosome-bearing cells in gonadoblastoma and dysgenetic testis in 45,X/46,XY infants. Mod Pathol 2005; 18: 439.
100. Birnbacher R, Marberger M, Weissenbacher G, et al. Gender identity reversal in an adolescent with mixed gonadal dysgenesis. J Pediatr Endocrinol Metab 1999; 12 (Suppl): 687-90.
101. Scully RE, Young RH, Clement RB. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament. 3rd series, Fascicle 23. Washington DC: Armed Forces Institute of Pathology, 1998.
102. Zhao S, Kato N, Endoh Y, Jin Z, et al. Ovarian gonadoblastoma with mixed germ cell tumor in a woman with 46, XX karyotype and successful pregnancies. Pathol Int 2000; 50: 332-5.
103. Jorgensen N, Muller J, Jaubert F, et al. Heterogeneity of gonadoblastoma germ cells: similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells. Histopathology 1997; 30: 177-86.
104. Hatano T, Yoshino Y, Kawashima Y, et al. Case of gonadoblastoma in a 9-year-old boy without physical abnormalities. Int J Urol 1999; 6: 164-6.
105. Muroya K, Ishii T, Nakahori Y, et al. Gonadoblastoma, mixed germ cell tumor, and Y chromosomal genotype: molecular analysis in four patients. Genes Chromosomes Cancer 1999; 25: 40-5.
106. Delbridge ML, Longepied G, Depetris D, et al. TSPY, the candidate gonadoblastoma gene on the human Y chromosome, has a widely expressed homologue on the X - implications for Y chromosome evolution. Chromosome Res 2004; 12: 345-56.
107. Iezzoni JC, von Kap-Herr C, Golden WL, et al. Gonadoblastomas in 45,X/46,XY mosaicism - Analysis of Y chromosome distribution by fluorescence in situ hybridization. Am J Clin Pathol 1997; 108: 197-201.
108. Kersemaekers AM, Honecker F, Stoop H, et al. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. Hum Pathol 2005; 36: 512-21.
109. Rey R, Sabourin JC, Venara M, et al. Anti-Mullerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors. Hum Pathol 2000; 31: 1202-8.
110. Hadjiathanasiou CG, Brauner R, Lortat-Jacob S, et al. True hermaphroditism: genetic variants and clinical management. J Pediatr 1994; 125: 738-44.
111. van Niekerk WA, Retief AE. The gonads of human true hermaphrodites. Hum Genet 1981; 58: 117-22.
112. Damiani D, Fellous M, McElreavey K, et al. True hermaphroditism: clinical aspects and molecular studies in 16 cases. Eur J Endocrinol 1997; 136: 201-4.
113. Guerra Junior G, de Mello MP, Assumpcao JG, et al. True hermaphrodites in the southeastern region of Brazil: a different cytogenetic and gonadal profile. J Pediatr Endocrinol Metab 1998; 11: 519-24.
114. Jimenez AL, Kofman-Alfaro S, Berumen J, et al. Partially deleted SRY gene confined to testicular tissue in a 46,XX true hermaphrodite without SRY in leukocytic DNA. Am J Med Genet 2000; 93: 417-20.
115. Slaney SF, Chalmers IJ, Affara NA, et al. An autosomal or X linked mutation results in true hermaphrodites and 46,XX males in the same family. J Med Genet 1998; 35: 17-22.
116. Talerman A, Verp MS, Senekjian E, et al. True hermaphrodite with bilateral ovotestes, bilateral gonadoblastomas and dysgerminomas, 46,XX/46,XY karyotype, and a successful pregnancy. Cancer 1990; 66: 2668-72.
117. Tanaka Y, Sasaki Y, Tachibana K, et al. Testicular juvenile granulosa cell tumor in an infant with X/XY mosaicism clinically diagnosed as true hermaphroditism. Am J Surg Pathol 1994; 18: 316-22.
118. nd ed. New York: Elsevier (in press).